利用核糖体基因区打靶载体靶向表达改造型人凝血因子ⅷ.pdfVIP

50 18 2005 9 * * † (, 410078. * . † , E-mail: nlmglcy@) hF (hF -BDDAK39) pHrneo-BDDAK39, (HT1080), hF -BDDAK39 . , pHrneo-BDDAK39 hF -BDDAK39 HT1080 , −5 6 − 1 − 1 2.0×10 , hF -BDDAK39 , (32±5)ng ·10 ·24 h . A . . () hF cDNAATG Kozak; () L303EF309S. . , 70% hF -BDDAK39 . , pHrneo, . pHrneo-BDDAK39, pHrneo-BDDAK39 . , (HT1080), , hF -BDDAK39 . . 1 , () . TaKaRa . , pcD-BDDAK39, PT2, pHrneo , HT- (pHrneo) 1080 ATCC, Roche (10−4~10−5). , α-32P-dCTP Perking-Elmer , Reverse , pHrneo A Transcription System Promega , . F CALBIOCHEM , , A , ()PIERCE , hF [1,2]. F ELISA CEDARLANE , [3,4] : () F cDNA, hF 1.2 kbmRNA, . PCR Roche . , () pHrneo-BDDAK39 . F ; () F Nhe /Pme pcD-BDDAK39, ; (